NVO Trading at $54.28 Price, 71% Global Market Share, Buy Rating
Novo Nordisk (NYSE:NVO) Stock Analysis: Growth Engine in Diabetes and Obesity, Risks From Competition and High CapEx
NYSE:NVO Share Price and Valuation
Novo Nordisk (NYSE:NVO) closed at $54.28 on September 8, 2025, after sliding 1.72% in the session. The company trades with a market capitalization of $245.92 billion, supported by trailing twelve-month revenue of DKK 311.9 billion ($45.7 billion) and net income of DKK 111.07 billion ($16.3 billion). Profit margins remain exceptional at 35.61%, with return on equity at a staggering 79.17%. Valuation ratios show a trailing P/E of 14.17 and forward P/E of 13.19, implying a discount relative to growth peers such as Eli Lilly (LLY), which trades above 35x forward earnings. Price-to-sales is…
